The Complete Guide to Testosterone Replacement Therapy

What Is Testosterone Replacement Therapy?

Testosterone Replacement Therapy (TRT) is the medical administration of exogenous testosterone to men whose bodies no longer produce adequate levels of the hormone endogenously. Hypogonadism — the clinical term for deficient testosterone production — is more common than most people realize, affecting an estimated 10–40% of men depending on the diagnostic criteria used. Its prevalence increases significantly with age, but it is far from exclusively an older man's condition.

Modern TRT, when properly managed, is not about chasing supraphysiological levels for performance enhancement. It is about restoring testosterone to a healthy, functional range and reclaiming the quality of life that low testosterone erodes quietly and progressively.

Signs and Symptoms of Low Testosterone

Low testosterone presents across multiple physiological systems, which is why it is often misdiagnosed or attributed to aging, depression, or other conditions. The most common symptoms include:

• Fatigue and low energy: Persistent tiredness that sleep does not resolve, reduced motivation, and a general sense of drag through daily activities.
• Reduced libido: Decreased sexual desire is one of the most consistent and diagnostically significant symptoms of hypogonadism.
• Erectile dysfunction: While ED has multiple causes, testosterone plays a critical role in maintaining normal erectile function.
• Loss of muscle mass and strength: Testosterone is the primary anabolic hormone. Low T leads to progressive muscle atrophy even in individuals who train regularly.
• Increased body fat: Particularly visceral fat accumulation around the abdomen, which itself further suppresses testosterone production through aromatization.
• Mood disturbances: Irritability, anxiety, depression, and emotional blunting are common. The relationship between testosterone and mood is bidirectional and well-established.
• Brain fog and cognitive decline: Difficulty concentrating, poor memory recall, and slowed cognitive processing are frequently reported.
• Reduced bone density: Over time, testosterone deficiency contributes to osteopenia and increases fracture risk.
• Sleep disturbances: Poor sleep quality and insomnia are common in hypogonadal men, and sleep deprivation further suppresses testosterone production.

Diagnosing Low Testosterone

Diagnosis requires blood testing. A comprehensive hormone panel should include:

• Total testosterone: The standard diagnostic marker. Most labs flag below 300 ng/dL as hypogonadal, though many men experience symptoms with levels between 300–500 ng/dL.
• Free testosterone: The biologically active fraction. SHBG (Sex Hormone-Binding Globulin) can be high enough to leave men with "normal" total testosterone but clinically low free testosterone.
• LH and FSH: Distinguishes primary (testicular) from secondary (pituitary/hypothalamic) hypogonadism and is essential for understanding the root cause.
• Estradiol (E2): Baseline estrogen levels guide AI use once TRT begins.
• Hematocrit and hemoglobin: Testosterone stimulates red blood cell production; baseline values are important for monitoring on therapy.
• PSA: Prostate-Specific Antigen baseline for men over 40, given testosterone's potential effect on prostate tissue.
• Metabolic panel and lipids: Comprehensive health baseline before initiating any hormone therapy.

Testing should be done in the morning (7–10 AM), when testosterone peaks, on at least two separate occasions before a diagnosis is confirmed.

TRT Options: Injectable vs. Other Delivery Methods

Testosterone can be administered via several routes, each with distinct characteristics:

• Subcutaneous or intramuscular injections: The most cost-effective and controllable delivery method. Allows precise dosing and frequency adjustment. This is the preferred method for most men seeking optimal outcomes.
• Transdermal gels and creams: Convenient but with variable absorption, skin transfer risk to partners and children, and frequently less stable serum levels.
• Pellets: Surgically implanted under the skin every 3–6 months. Eliminates injection burden but provides no ability to adjust dose between pellet insertions.
• Oral/buccal: Limited options, generally less favored due to liver metabolism concerns or inconsistent absorption.

Injectable testosterone remains the gold standard for most men who prioritize efficacy, control, and cost-effectiveness.

Test Cypionate vs. Test Enanthate: What's the Difference?

The two most commonly used injectable testosterone esters are Testosterone Cypionate and Testosterone Enanthate. Both are long-acting esters of testosterone, but they have subtle differences worth understanding:

Testosterone Cypionate

• Half-life: approximately 8 days
• Traditionally the dominant ester in North American medical practice
• Slightly more oil-based, with a marginally smoother release profile for some users
• Typically dosed at 100–200 mg per week for TRT

Testosterone Enanthate

• Half-life: approximately 4.5–5 days (slightly shorter than cypionate)
• The dominant ester in European medical practice
• The shorter half-life can allow for more frequent dosing with smaller peaks and troughs
• Interchangeable with cypionate for most TRT purposes

In practice, the differences between these two esters are clinically minor. The choice often comes down to availability, preference, and individual response. Some men find they tolerate one ester slightly better than the other, but most do equally well on either. Testosterone Sustanon (a blend of four esters) is another option, though it requires more frequent injection due to its short-ester components.

TRT Protocols

Starting Protocol

A typical starting TRT protocol for a man with confirmed hypogonadism:

• Testosterone Cypionate or Enanthate: 100–150 mg per week, injected subcutaneously or intramuscularly
• Injection frequency: Many endocrinologists start with once-weekly injections for simplicity, though twice-weekly (dividing the dose in half) produces more stable serum levels and is preferred by most experienced TRT practitioners
• Aromatase inhibitor: Not started automatically — only introduced if estradiol rises to symptomatic levels upon follow-up bloodwork

Optimization and Dose Adjustment

Blood work should be repeated 6–8 weeks after initiating TRT, timed as a trough draw (the morning of your next injection, before injecting). Target levels vary by individual but most practitioners aim for:

• Total testosterone: 600–1000 ng/dL
• Free testosterone: upper third of reference range
• Estradiol: 20–40 pg/mL (sensitive assay)
• Hematocrit: below 52–54%

Managing Estrogen on TRT

Exogenous testosterone aromatizes to estradiol, and estrogen management is one of the more nuanced aspects of TRT. Many men on well-calibrated TRT protocols do not need an aromatase inhibitor at all — estrogen has important functions in men including bone density, libido, cardiovascular health, and cognitive function. Over-suppression of estrogen produces its own constellation of symptoms that mirror low testosterone.

When an AI is needed, anastrozole (Arimidex) or exemestane (Aromasin) are the most common choices. See our dedicated Arimidex vs. Aromasin guide for full details.

Long-Term Monitoring

Men on TRT should have blood work performed every 3–6 months once stable, monitoring:

• Total and free testosterone
• Estradiol
• Hematocrit and hemoglobin
• PSA (annually for men over 40)
• Lipid panel and metabolic markers
• Liver enzymes (particularly relevant for oral compounds, though injectable testosterone has minimal hepatotoxicity)

Frequently Asked Questions

Will TRT shut down my natural testosterone production?

Yes. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis via negative feedback, reducing LH and FSH and consequently shutting down endogenous testosterone production. This is expected and manageable. Men who want to preserve fertility or the option to come off TRT may use HCG (human chorionic gonadotropin) alongside their protocol to maintain testicular function.

Is TRT safe long-term?

Decades of clinical data support the safety of appropriately dosed TRT in hypogonadal men. The primary concerns — cardiovascular risk and polycythemia — are manageable with proper monitoring. The cardiovascular data has become increasingly favorable; the TRAVERSE trial found no increase in major adverse cardiac events in TRT-treated men.

What is the difference between TRT and steroid use?

TRT aims to restore testosterone to normal physiological levels. Anabolic steroid use in bodybuilding involves supraphysiological doses — often 3–10 times the therapeutic TRT range — with entirely different risk profiles and objectives. The two should not be conflated.

Can TRT help with mental health?

For men with confirmed hypogonadism, TRT frequently produces meaningful improvements in mood, motivation, and emotional resilience. It is not a treatment for clinical depression in eugonadal men, but for hypogonadal men, correcting the hormone deficiency often has dramatic psychological effects.

Where do I get started?

VORN offers Test Cypionate and Test Enanthate for those working with a prescribing physician. Many men also use Arimidex or Aromasin as part of their TRT management protocol.